An Illinois mistrial involving the recalled medication Zantac is the latest court decision involving the recalled drug, but ...

GlaxoSmithKline has found a replacement for head of vaccines R&D Emmanuel Hanon, who left the company for a US biotech earlier this year, hiring Phil Dormitzer from ...

The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

Walmsley confirmed that the company was interested in bidding for Pfizer’s consumer healthcare business, but refused to comment on whether paying out the necessary billions would hit GSK’s ...

GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents ...

Shares of Pfizer, Moderna, and GSK tumbled Wednesday as decisions by a key Centers for Disease Control and Prevention ...

Painkiller brands Panadol and Anadin will be bought under one roof under a giant deal between drug firms GlaxoSmithKline and Pfizer. The firms are combining their consumer healthcare businesses ...

Former Zantac makers GSK, Pfizer, Sanofi and Boehringer Ingelheim are facing about 4,000 claims in California state court and about 2,000 in various other state courts around the country.

Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on Wednesday night. | Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on ...

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

Congress in Spain were a major feature of research news last week, including those from Pfizer on it ponsegromab in cancer ...